While CMS may not consider such accreditation sufficient, many companies still seek it
While CMS may not consider such accreditation sufficient, many companies still seek it
Certification by the Joint Commission on Accreditation of Healthcare Organizations has become a useful way for teleradiology companies to speed up the process of getting credentialed by local providers. By the end of the year, as many as two dozen will have signed up for the program.
JCAHO has offered accreditation to teleradiology companies under its ambulatory care organization rules since 2003. Local providers of imaging services that require JCAHO accreditation for teleradiology companies with which they contract can avoid the more rigorous checks they would need to conduct on their own.
The commission sets a number of administrative performance requirements for ambulatory care providers. A crucial one for teleradiology providers is that they be boarded in the U.S.
"Accrediting simplifies the process of getting the hospital contract," said Mike Dye, senior associate director of business development for JCAHO. "Accreditation from the Joint Commission is often all the hospital needs. It has usually gone through the same process to vouch for its own radiologists."
Not all agree that JCAHO accreditation will be sufficient, however. An August 2006 report from HortySpringer publications suggests that the Centers for Medicare and Medicaid Services does not approve of "privileging by proxy" and expects hospitals to credential and privilege teleradiologists through their medical staff process.
Despite that report, CMS hasn't come down firmly with a ruling on the issue or taken any action to enforce that position, said Michael Kulczycki, executive director of ambulatory care accreditation programs for JCAHO.
"The Joint Commission vice president of standards has been in discussions with CMS about that issue for almost a year. It is not final," Kulczycki said.
Many of the larger teleradiology companies either have or are seeking JCAHO accreditation, although there remain dozens of mostly smaller providers that have not. In addition to those who are in the process of obtaining accreditation, another 50 or so have inquired, Dye said.
It costs about $8000 to obtain a diagnostic accreditation that is valid for three years. Periodic reviews will be conducted during that time, including one unannounced site visit in the third year.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.